V

VERTANICAL

Develops cannabinoid-based therapies for chronic pain

Medical Sales Representative

Field SalesUpdated on Nov 6
Full-timeGermanyNo salary listedIn-person

About the Job

Requirements

  • Authorization under §75 of the German Medicines Act is required.
  • Initial experience in physician field sales and an existing network of relevant contacts are advantageous; motivated entry-level candidates are also welcome.
  • Experience in pain therapy is advantageous.
  • The candidate should be able to engage credibly with relevant physicians and opinion leaders.
  • The candidate should demonstrate persuasive sales ability, independence, structured work, and a results- and sales-oriented approach.

Responsibilities

  • Support specialist and general practitioners in the assigned territory and persuade and train them on the optimal use of the company's cannabis medicines.
  • Develop, organize, and deliver high-quality training sessions in medical practices and clinics.
  • Take responsibility for an assigned physician territory and pursue targets independently.
  • Attend regional and national congresses and symposia, represent the company in person, and engage with relevant specialists and opinion leaders.
  • Build long-term relationships with pain-therapy opinion leaders in the region and serve as their primary contact.
  • Identify relevant networks in the territory, organize referral events, and conduct product training for target customers.

Desired Qualifications

  • Experience in physician field sales and an existing network of relevant contacts.
  • Experience in pain therapy.

About the Company

VERTANICAL

Develops cannabinoid-based therapies for chronic pain

VERTANICAL develops therapies for chronic pain. Its lead product, VER-01, is a cannabinoid-based treatment designed to relieve pain and also help with common comorbid problems like sleep disorders and reduced physical function. The company aims to move beyond simple pain relief by addressing multiple related symptoms and to set new standards in pain therapy with VER-01 becoming the leading treatment for chronic pain by 2030. Compared with competitors, VERTANICAL emphasizes a global leadership position through a focused cannabinoid approach and a mission to significantly reduce the burden of chronic pain. The overarching goal is a world free of chronic pain.

Company size
11-50
Company stage
Not listed
Total funding
Not listed
Headquarters
Gräfelfing, Germany
Founded
2017

Recently Posted Jobs

Explore more opportunities at VERTANICAL

See more jobs